TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23354314

Group type: EXPERIMENTAL
Intervention: Mild water‐filtered near infrared whole body hyperthermia once a week
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Mild water‐filtered near infrared whole body hyperthermia twice a week
Number of subjects: 67

Group type: COMPARATOR
Intervention: Standard multimodal rehabilitation
Number of subjects: 67
Study: 21700419

Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unmedicated condition
Number of subjects: 0
Study: 18469732

Group type: EXPERIMENTAL
Intervention: Probiotic Escherichia coli Nissle 1917 (EcN) suspension (1-3 mL daily for 21 days)
Number of subjects: 151
Study: 16556690

Group type: EXPERIMENTAL
Intervention: Inhaled human insulin (INH)
Number of subjects: 226

Group type: COMPARATOR
Intervention: Subcutaneous insulin (SC)
Number of subjects: 226
Study: 12545256

Group type: EXPERIMENTAL
Intervention: Open craniotomy and resection of the tumour
Number of subjects: 30

Group type: COMPARATOR
Intervention: Stereotactic biopsy
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Radiotherapy (amount given)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both treatments (Open craniotomy and Stereotactic biopsy)
Number of subjects: 30
Study: 14629844

Group type: EXPERIMENTAL
Intervention: Acupuncture in addition to standard care (n = 11)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Acupressure and standard care (n = 17)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Standard care alone (n = 13)
Number of subjects: 41
Study: 10637151

Group type: EXPERIMENTAL
Intervention: IgA-seropositive men
Number of subjects: 129

Group type: COMPARATOR
Intervention: IgA-seronegative men
Number of subjects: 129
Study: 8727434

Group type: EXPERIMENTAL
Intervention: Low-dose dopamine infusion (2 micrograms.kg-1.min-1) during 2-hour periods
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Low-dose dopamine infusion (2 micrograms.kg-1.min-1) after 48 hours
Number of subjects: 29

Group type: COMPARATOR
Intervention: Low-dose dopamine infusion (2 micrograms.kg-1.min-1)
Number of subjects: 29
Study: 1888820

Group type: EXPERIMENTAL
Intervention: 50 mg fluconazole daily for 14‐28 days
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 150 mg fluconazole weekly for 6 months
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo weekly for 6 months
Number of subjects: 16
Study: 6384850

Group type: EXPERIMENTAL
Intervention: Cefoxitin (2 g, 12 doses)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Socioeconomic status
Number of subjects: 70
Study: 3532966

Group type: EXPERIMENTAL
Intervention: Cyclosporin (10 mg/kg daily for two months)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 31652561

Group type: EXPERIMENTAL
Intervention: SuperbaBoostTM krill oil
Number of subjects: 0

Group type: COMPARATOR
Intervention: Choline bitartrate
Number of subjects: 0
Study: 29231607

Group type: EXPERIMENTAL
Intervention: Combined therapy of regular acupuncture and contralateral needling technique at distal acupoints
Number of subjects: 60

Group type: COMPARATOR
Intervention: Regular acupuncture
Number of subjects: 60
Study: 26383189

Group type: EXPERIMENTAL
Intervention: Coblation tonsillectomy
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Diode laser tonsillectomy
Number of subjects: 120

Group type: COMPARATOR
Intervention: Cold dissection tonsillectomy
Number of subjects: 120
Study: 23550665

Group type: EXPERIMENTAL
Intervention: Cognitive Stimulation Therapy Japanese version (CST-J), 14 sessions, twice a week for 7 weeks
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Cognitive Stimulation Therapy Japanese version (CST-J)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 56
Study: 21470248

Group type: EXPERIMENTAL
Intervention: 0.5% plain ropivacaine
Number of subjects: 60

Group type: COMPARATOR
Intervention: 4% articaine with epinephrine 1:100,000
Number of subjects: 60
Study: 17978857

Group type: EXPERIMENTAL
Intervention: Intraoperative single bolus rabbit ATG in a dose of 9 mg/kg
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (no ATG)
Number of subjects: 80
Study: 16857836

Group type: EXPERIMENTAL
Intervention: FeSO4
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Electrolytic iron powder
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Electrolytic iron powder with ascorbic acid
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: FeSO4 with phytic acid
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Electrolytic iron with phytic acid
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: FeSO4 (3 mg vs 20 mg)
Number of subjects: 56
Study: 15298823

Group type: EXPERIMENTAL
Intervention: Support Health Visitor (SHV) intervention
Number of subjects: 731

Group type: EXPERIMENTAL
Intervention: Community Group Support (CGS) intervention
Number of subjects: 731

Group type: COMPARATOR
Intervention: Standard services (Control)
Number of subjects: 731
Study: 11528497

Group type: EXPERIMENTAL
Intervention: Z-scores of height-for-age
Number of subjects: 3055

Group type: EXPERIMENTAL
Intervention: Z-scores of weight-for-age
Number of subjects: 3055

Group type: EXPERIMENTAL
Intervention: Z-scores of weight-for-height
Number of subjects: 3055
Study: 9268948

Group type: EXPERIMENTAL
Intervention: MVP (platinum-based chemotherapy)
Number of subjects: 156

Group type: COMPARATOR
Intervention: MACC (non-platinum-based combination chemotherapy)
Number of subjects: 156
Study: 8274720

Group type: EXPERIMENTAL
Intervention: r-interferon alpha 2a (IFM)
Number of subjects: 305

Group type: EXPERIMENTAL
Intervention: acyclovir (ACV)
Number of subjects: 305

Group type: COMPARATOR
Intervention: vitamin therapy
Number of subjects: 305
Study: 3544860

Group type: EXPERIMENTAL
Intervention: Pulsatile glucagon infusion (812.5 ng X min‐1, 2/11 min on/off)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Continuous glucagon infusion (125 ng X min‐1)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Pulsatile glucagon infusion
Number of subjects: 6
Study: 28478984

Group type: EXPERIMENTAL
Intervention: Walking Bleaching (WB) technique; sodium perborate and 20% hydrogen peroxide applied in pulp chambers, replaced weekly for 4 weeks
Number of subjects: 17

Group type: COMPARATOR
Intervention: Inside-Outside (I-O) technique; 10% carbamide peroxide applied in pulp chambers, worn in custom-fitted trays for 1 hour per day over 4 weeks
Number of subjects: 17
Study: 27629844

Group type: EXPERIMENTAL
Intervention: PPI + AMO + CLA
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Sequential therapy
Number of subjects: 69

Group type: COMPARATOR
Intervention: PPI + AMO + MET
Number of subjects: 69
Study: 26677667

Group type: EXPERIMENTAL
Intervention: ZHU's Tiaojing Cuyun Recipe (TCR), one dose per day for 2 courses (3 menstrual cycles each).
Number of subjects: 80

Group type: COMPARATOR
Intervention: Clomifene Citrate (CC), 50 mg per day for 2 courses (3 menstrual cycles each).
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: ZHU's TCR
Number of subjects: 80

Group type: COMPARATOR
Intervention: Clomifene Citrate (CC)
Number of subjects: 80
Study: 22975216

Group type: EXPERIMENTAL
Intervention: Peg‐IFN 100 μg SC once weekly for 36 months
Number of subjects: 896

Group type: COMPARATOR
Intervention: IFN 3 MU SC three times weekly for 18 months
Number of subjects: 896
Study: 21182802

Group type: EXPERIMENTAL
Intervention: Self-administered questionnaire
Number of subjects: 328

Group type: COMPARATOR
Intervention: Face-to-face interview
Number of subjects: 328
Study: 18337596

Group type: EXPERIMENTAL
Intervention: Acyclovir (400 mg twice daily)
Number of subjects: 821

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 821
Study: 17139367

Group type: EXPERIMENTAL
Intervention: Aspirin (325 mg daily)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Clopidogrel (75 mg daily)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Cilostazol (100 mg twice daily)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Combination of clopidogrel and aspirin
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Combination of clopidogrel and cilostazol
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Triple-drug combination (aspirin, clopidogrel, cilostazol)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control subjects (not treated)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 26
Study: 12707866

Group type: EXPERIMENTAL
Intervention: Pain education booklet
Number of subjects: 51

Group type: COMPARATOR
Intervention: Standard care comparison group
Number of subjects: 51
Study: 11112089

Group type: EXPERIMENTAL
Intervention: Atorvastatin with evening meals
Number of subjects: 16

Group type: COMPARATOR
Intervention: Atorvastatin after meals
Number of subjects: 16
Study: 9071860

Group type: EXPERIMENTAL
Intervention: Health education to promote exclusive breast feeding (using flip-charts, videos, and photographs)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Health education to promote exclusive breast feeding
Number of subjects: 120
Study: 8383874

Group type: EXPERIMENTAL
Intervention: Physical training programme (8 months) in boys from the hypertensive subgroup
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Physical training programme (8 months) in boys from the normotensive subgroup
Number of subjects: 80

Group type: COMPARATOR
Intervention: Cross-sectional evaluation of sodium-potassium pump activity
Number of subjects: 80
Study: 3084617

Group type: EXPERIMENTAL
Intervention: Sodium valproate (DPA) 400 mg orally
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 30625216

Group type: EXPERIMENTAL
Intervention: Multiple POV video system (EG)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Single POV system (CG)
Number of subjects: 30
Study: 29153282

Group type: EXPERIMENTAL
Intervention: Elastic memory chains (EMCs)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Nickel-titanium (NiTi) coil springs
Number of subjects: 21
Study: 26061686

Group type: EXPERIMENTAL
Intervention: Radiofrequency Ablation (RFA) using an 18-Gauge internally cooled electrode
Number of subjects: 80

Group type: COMPARATOR
Intervention: Observation (Control group)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Radiofrequency Ablation (RFA)
Number of subjects: 80
Study: 23752780

Group type: EXPERIMENTAL
Intervention: Device-guided breathing (aiming at <10 breaths/min)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Sham device (music without aiming at lowering of breathing frequency)
Number of subjects: 48
Study: 21898705

Group type: EXPERIMENTAL
Intervention: Attention and Interpretation Modification (AIM)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Cognitive Bias Modification for Attention (CBM-A)
Number of subjects: 32
Study: 19755888

Group type: EXPERIMENTAL
Intervention: 11-minute video about home management of fever
Number of subjects: 280

Group type: COMPARATOR
Intervention: Control video about child safety
Number of subjects: 280
Study: 16980907

Group type: EXPERIMENTAL
Intervention: Carraguard (carrageenan-derived microbicide gel)
Number of subjects: 165

Group type: COMPARATOR
Intervention: Placebo (methylcellulose gel)
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Carraguard and Placebo
Number of subjects: 165
Study: 12738504

Group type: EXPERIMENTAL
Intervention: Soy-derived isoflavones (72 mg daily)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study: 10692619

Group type: EXPERIMENTAL
Intervention: Strength training
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Muscular endurance training
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Coordination training
Number of subjects: 103

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Exercise groups (combined)
Number of subjects: 103
Study: 9285659

Group type: EXPERIMENTAL
Intervention: Low-dose amiodarone (10 mg/kg/day for a minimum of 14 days, followed by 200 mg/day for maintenance)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Conventional antiarrhythmic drug therapy (sotalol or propafenone)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Low-dose amiodarone
Number of subjects: 400

Group type: COMPARATOR
Intervention: Conventional antiarrhythmic drug therapy
Number of subjects: 400
Study: 8222496

Group type: EXPERIMENTAL
Intervention: L-365,260 50 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: L-365,260 (all doses combined)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 3534862

Group type: EXPERIMENTAL
Intervention: Captopril (50 mg two times a day) for 8 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Chlorthalidone (25 mg/day) for 8 weeks
Number of subjects: 40
Study: 30201572

Group type: EXPERIMENTAL
Intervention: SER–In (slow eating rate protocol with earplugs)
Number of subjects: 12

Group type: COMPARATOR
Intervention: SER–Out (slow eating rate protocol without earplugs)
Number of subjects: 12

Group type: COMPARATOR
Intervention: NER (normal eating rate)
Number of subjects: 12
Study: 26852712

Group type: EXPERIMENTAL
Intervention: Tubridge flow diverter (FD)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Coils (as a supplementary measure)
Number of subjects: 6
Study: 25023977

Group type: EXPERIMENTAL
Intervention: Cinnarizine (1.5 mg/kg/day for children <30 kg or 50 mg for children >30 kg, administered at bedtime)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study: 22258133

Group type: EXPERIMENTAL
Intervention: Therapeutic hypothermia (cooled group)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 135
Study: 20146009

Group type: EXPERIMENTAL
Intervention: Completion of Health Utilities Index Mark 2 (HUI2) and Mark 3 (HUI3) on touch‐screen computer with feedback to clinicians
Number of subjects: 213

Group type: COMPARATOR
Intervention: Completion of HUI2 and HUI3 on touch‐screen computer without feedback
Number of subjects: 213
Study: 18004920

Group type: EXPERIMENTAL
Intervention: Maxillary canines (treatment group)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Mandibular canines (control group)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Maxillary microscrew implants (implant group)
Number of subjects: 10
Study: 16408384

Group type: EXPERIMENTAL
Intervention: Formula supplemented with 0.4 g/100ml oligosaccharides (9 to 1 mixture of galacto- and fructooligosaccharides)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Control formula
Number of subjects: 97
Study: 12411452

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention (hypocaloric DASH diet + exercise program)
Number of subjects: 44
Study: 10466854

Group type: EXPERIMENTAL
Intervention: Scheduled within 48 hours of telephone intake (Group 1)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Reminder call 24 hours prior to appointment (Group 2)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Appointment card and clinic brochure in the mail (Group 3)
Number of subjects: 128

Group type: COMPARATOR
Intervention: No intervention (Group 4)
Number of subjects: 128
Study: 9931077

Group type: EXPERIMENTAL
Intervention: Nifedipine (all formulations)
Number of subjects: 5290

Group type: COMPARATOR
Intervention: Other active drug controls
Number of subjects: 5290

Group type: EXPERIMENTAL
Intervention: Immediate-release nifedipine
Number of subjects: 5290

Group type: EXPERIMENTAL
Intervention: Nifedipine monotherapy
Number of subjects: 5290
Study: 1808221

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided anterior subcostal liver biopsy (USAB)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Menghini technique
Number of subjects: 200
Study: 6411792

Group type: EXPERIMENTAL
Intervention: Enteral feeding (Vivonex HN) via needle catheter jejunostomy (NCJ) starting at 18 hours postoperatively, advanced to 3,000 cc/day within 72 hours.
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (no supplemental nutrition during first five postoperative days).
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Enteral feeding group.
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group.
Number of subjects: 26
Study: 30702173

Group type: EXPERIMENTAL
Intervention: TLM-KTP
Number of subjects: 20

Group type: COMPARATOR
Intervention: TLM-CO2
Number of subjects: 20
Study: 28174369

Group type: COMPARATOR
Intervention: Erich's arch bar and wires (Group I)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Self-tapping IMF screw (Group II)
Number of subjects: 20
Study: 23611397

Group type: EXPERIMENTAL
Intervention: EndoActivator
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Vibringe
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Conventional irrigation (17% EDTA followed by 6% NaOCl)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control (saline)
Number of subjects: 50
Study: 22131601

Group type: EXPERIMENTAL
Intervention: Zolpidem 10 mg
Number of subjects: 95

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 95
Study: 19039085

Group type: EXPERIMENTAL
Intervention: Individually adjusted GH dose (IAD) starting at 0.035 mg/kg per day, increased to 0.067 mg/kg per day if growth prediction was <0.75 at 3 months
Number of subjects: 179

Group type: COMPARATOR
Intervention: Fixed high GH dose (FHD) at 0.067 mg/kg per day throughout the study
Number of subjects: 179
Study: 17133185

Group type: EXPERIMENTAL
Intervention: CV(prone)-HFOV(supine)
Number of subjects: 43

Group type: COMPARATOR
Intervention: CV(prone)-CV(supine)
Number of subjects: 43

Group type: COMPARATOR
Intervention: CV(supine)-HFOV(supine)
Number of subjects: 43
Study: 15126234

Group type: EXPERIMENTAL
Intervention: SSRI group (paroxetine 10 mg-40 mg/day and sertraline 50 mg-150 mg/day)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: SSRI group
Number of subjects: 30
Study: 11159288

Group type: EXPERIMENTAL
Intervention: Chiropractic spinal manipulation
Number of subjects: 86

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 86
Study: 9146858

Group type: EXPERIMENTAL
Intervention: Phenytoin (PHT) 100 mg single oral dose
Number of subjects: 6
Study: 3622539

Group type: EXPERIMENTAL
Intervention: Nalbuphine (≤ 20 mg)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Diamorphine (≤ 5 mg)
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Nalbuphine
Number of subjects: 176

Group type: COMPARATOR
Intervention: Diamorphine
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Nalbuphine and Diamorphine
Number of subjects: 176
Study: 29785926

Group type: EXPERIMENTAL
Intervention: Intramedullary nail fixation (n=161)
Number of subjects: 321

Group type: COMPARATOR
Intervention: Locking plate fixation (n=160)
Number of subjects: 321
Study: 27624567

Group type: EXPERIMENTAL
Intervention: Preventive home visits (PHV) offered to frail elderly persons
Number of subjects: 553

Group type: COMPARATOR
Intervention: Control group (no PHV)
Number of subjects: 553
Study: 25045825

Group type: EXPERIMENTAL
Intervention: MF59®-adjuvanted trivalent influenza vaccine (aTIV)
Number of subjects: 7082

Group type: COMPARATOR
Intervention: Non-adjuvanted seasonal influenza vaccine (TIV)
Number of subjects: 7082
Study: 22931623

Group type: EXPERIMENTAL
Intervention: Coplanar decile intensity-modulated radiotherapy (IMRT)
Number of subjects: 10

Group type: COMPARATOR
Intervention: 3D-conformal radiotherapy (3D-CRT)
Number of subjects: 10
Study: 19632065

Group type: EXPERIMENTAL
Intervention: Palliative radiotherapy
Number of subjects: 909
Study: 17828605

Group type: EXPERIMENTAL
Intervention: PCLR prostheses
Number of subjects: 100

Group type: COMPARATOR
Intervention: PCLS prostheses
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: PCLR and PCLS prostheses
Number of subjects: 100
Study: 16396699

Group type: EXPERIMENTAL
Intervention: Amtolmetin guacyl (AMG) 600 mg twice daily
Number of subjects: 235

Group type: COMPARATOR
Intervention: Celecoxib 200 mg twice daily
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: Both AMG and celecoxib
Number of subjects: 235
Study: 12573744

Group type: EXPERIMENTAL
Intervention: Continuous hyperfractionated accelerated radiotherapy (V-CHART) with mitomycin C (20 mg/m² on day 5)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Continuous hyperfractionated accelerated radiotherapy (V-CHART) without mitomycin C
Number of subjects: 62

Group type: COMPARATOR
Intervention: Conventional fractionation
Number of subjects: 62
Study: 10534796

Group type: EXPERIMENTAL
Intervention: Trunk extensor endurance training (exercise sessions 3 times a week for 6 weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no exercises, received back care advice and hot packs 3 to 5 times per week)
Number of subjects: 0
Study: 8916639

Group type: EXPERIMENTAL
Intervention: Psychodynamic‐interpersonal therapy (16 sessions)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Cognitive‐behavioral therapy (16 sessions)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Psychodynamic‐interpersonal therapy (8 sessions)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Cognitive‐behavioral therapy (8 sessions)
Number of subjects: 36

Group type: COMPARATOR
Intervention: CPP clients (combined treatment approaches)
Number of subjects: 36

Group type: COMPARATOR
Intervention: SPP2 clients (combined treatment approaches)
Number of subjects: 36
Study: 1533259

Group type: EXPERIMENTAL
Intervention: Chlorthalidone (50 mg/day)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Atenolol (100 mg/day)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Enalapril (20-40 mg/day)
Number of subjects: 50
Study: 6498701

Group type: EXPERIMENTAL
Intervention: Migraine group (n=100)
Number of subjects: 169

Group type: COMPARATOR
Intervention: Control group (n=100)
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 169
Study: 30763661

Group type: EXPERIMENTAL
Intervention: 18 Gy hyperfractionated radiation therapy (RT) given in twice-daily fractions of 1.5 Gy each
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: 18 Gy hyperfractionated RT
Number of subjects: 25
Study: 30095381

Group type: EXPERIMENTAL
Intervention: Vancomycin (VCM) 1 g
Number of subjects: 230

Group type: COMPARATOR
Intervention: Ampicillin (AMP) 1 g
Number of subjects: 230
Study: 26863323

Group type: EXPERIMENTAL
Intervention: Moderate hypoxia (FiO2 = 15.0%)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Normoxia (FiO2 = 20.9%)
Number of subjects: 8
Study: 24977247

Group type: EXPERIMENTAL
Intervention: Cosci technique
Number of subjects: 15

Group type: COMPARATOR
Intervention: Summers technique
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 15